Pharmaceutical Technology

MAY 30, 2023

Genmab AS’s epcoritamab presents as the top European drug launch and only oncological therapy. Notably, the roster of future blockbusters predominantly comprises therapeutics targeting the central nervous system (CNS), accounting for three of the top five drug launches.

Drugs 264

Drugs Sales Antibody Dermatology 264

Pharmaceutical Technology

OCTOBER 6, 2023

Ocular Therapeutix has confirmed the launch of a trial of an intravitreal eye implant intended to combat macular degeneration.

Trials 246

Trials 246

Pharmaceutical Technology

JULY 4, 2023

Abeona Therapeutics has raised $25m from its current select investors to launch and commercialise its cell therapy, EB-101.

264

264

Pharmaceutical Technology

NOVEMBER 21, 2023

The new scheme will launch in 2024 and aims to save the National Health Service (NHS) £14bn over five years.

Clinical Trials 246

Clinical Trials Clinical Trials Medicine Trials 246

Pharmaceutical Technology

MARCH 22, 2024

Mirador Therapeutics has announced its launch, securing more than $400m in funding to develop precision medicines.

Development 130

Development Medicine 130

Bio Pharma Dive

JULY 27, 2023

But at the beginning it’s predicting a slower launch than for its fast-selling shingles shot. GSK expects its respiratory syncytial virus vaccine will be a multibillion dollar product.

Vaccination 246

Vaccination Vaccine Production 246

Bio Pharma Dive

MAY 15, 2023

Vetter brings a proven launch management process that combines extensive experience with in-depth product knowledge.

Production 256

Production Drugs 256

Pharmaceutical Technology

MARCH 15, 2024

Noramco has announced the launch of Noramco Group, a North American pharmaceutical supply chain services provider.

130

130

Pharmaceutical Technology

NOVEMBER 1, 2022

FEATURED COMPANIES COMMENDED : • Innovation • Product Launch • Safety VIEW PROFILE COMMENDED : • Business Expansion • Innovation • Investments VIEW PROFILE COMMENDED: • Social VIEW PROFILE. What are Product Launches? The Product Launches category recognises companies that have launched notable new products or services into the market.

Production 130

Production Marketing Manufacturing Vaccination 130

Pharmaceutical Technology

FEBRUARY 12, 2024

Alys Pharmaceuticals has announced its launch with a R&D pipeline, backed by a $100m financing from Medicxi.

130

130

BioSpace

APRIL 24, 2024

on Wednesday launched an investigation into the exorbitant prices of Novo Nordisk’s Ozempic and Wegovy blockbusters, and has asked the Danish drugmaker to justify their price tags. Bernie Sanders (I-Vt.)

99

99

Pharmaceutical Technology

JANUARY 25, 2024

Synnovation Therapeutics has launched with a $102m Series A financing to progress the development its pipeline of targeted therapies.

Development 130

Development 130

pharmaphorum

MARCH 26, 2024

Learn more about the expensive failure to launch of these medications. Aduhelm (aducanumab) and Leqembi are examples of controversial drugs that faced challenges with FDA approval.

FDA Approval 107

FDA Approval Drugs 107

BioSpace

APRIL 25, 2024

Pfizer will go toe-to-toe with CSL Behring following the FDA’s Friday approval of its hemophilia B gene therapy Beqvez and will launch a warranty program based on the durability of response.

Gene Therapy 90

Gene Therapy Gene FDA Approval 90

World of DTC Marketing

APRIL 5, 2022

The old model of looking at performance in the first six months of product launch isn’t relevant. Today, colossal budget product launches are not returning the same ROI as before. Product launches are going to need to be micro-targeted to specific audiences. What is the definition of a successful pharma product launch?

Production 196

Production Pharma Companies Branding Marketing 196

Pharmaceutical Technology

JANUARY 22, 2024

An analysis of GlobalData’s analyst consensus sales and forecast database reveals that three out of 12 novel oncology brands that launched globally from November 2022 to December 2023 have the potential to reach blockbuster sales.

Branding 130

Branding Sales 130

Pharma Times

APRIL 22, 2024

The launch is part of the NIHRs £42m funding to establish 14 new HRCs across England

Medicine 110

Medicine Research 110

Pharmaceutical Technology

MAY 25, 2023

Clover Biopharmaceuticals has established a commercial collaboration with Keyuan Xinhai (Beijing) Medical Products Trading (Kyuan Trade) for the launch of its quadrivalent seasonal influenza vaccine, AdimFlu-S (QIS), in China. Clover Biopharmaceuticals expects to launch the influenza vaccine in the second half of 2023.

Vaccination 262

Vaccination Vaccine Containment Sales 262

Pharmaceutical Technology

JUNE 13, 2023

The British investment trust Syncona Limited launched the new ophthalmic gene therapy company by combining Applied Genetic Technologies Corporation’s (AGTC’s) late-stage X-linked retinitis pigmentosa (XLRP) programme with two proprietary preclinical programmes. Beacon Therapeutics is the third gene therapy company Syncona has launched.

Gene Therapy 246

Gene Therapy Gene Trials Clinical Trials 246

Pharmaceutical Technology

OCTOBER 7, 2022

Provention Bio and Sanofi US have signed a co-promotion agreement to launch the former’s lead investigational drug candidate, teplizumab for the delay in the onset of clinical type 1 diabetes (T1D). The agreement aids Provention in leveraging the capabilities and commercial resources of Sanofi to back teplizumab’s launch.

FDA Approval 299

FDA Approval Licensing Licensing Antibody 299

Pharmaceutical Technology

JUNE 6, 2023

Alkeus Pharmaceuticals has raised $150m in Series B financing to support the registration and launch of gildeuretinol (ALK-001) to treat Stargardt disease, a genetic cause of blindness in children and young adults.

Genetics 279

Genetics Life Science Trials Clinical Development 279

BioSpace

APRIL 14, 2024

While the VC fund launched on Monday by Regeneron Pharmaceuticals has an investment mandate that includes healthcare broadly, Regeneron Ventures will lean towards biotechnology, devices, tools and enabling technologies.

85

85

BioSpace

APRIL 17, 2024

Teva Pharmaceuticals and Alvotech got the FDA’s greenlight for their biosimilar to Johnson & Johnson’s blockbuster Stelara, which will launch in the U.S. in February 2025.

FDA Approval 93

FDA Approval 93

pharmaphorum

FEBRUARY 6, 2024

Right after the official launch of the new Apple Vision Pro mixed reality headset, Cedars-Sinai has launched a generative artificial intelligence (genAI) app that will use the technology to provide mental health support for patients.

106

106

Pharmaceutical Technology

OCTOBER 11, 2023

Gritgen Therapeutics has launched operations at its commercial GMP facility in Suzhou Industrial Park, China.

147

147

BioPharma Reporter

FEBRUARY 26, 2024

Neuraxpharm Group, a European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has announced the first launch of BRIUMVI (ublituximab) in Europe for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease.

Development 104

Development 104

World of DTC Marketing

DECEMBER 9, 2021

The days of enormous product launch budgets are over unless a new mass-market product is introduced. One top-10 pharma company has created a “market launch metric” team to measure key launch milestones. ” The post Do you have enough money to launch your drug?

Drugs 204

Drugs Branding Marketing Production 204

Drug Discovery World

APRIL 19, 2024

Charles River Laboratories International has launched its Alternative Methods Advancement Project (AMAP), an initiative focused on developing alternatives to reduce animal testing. The recent launch of Endosafe Trillium, the company’s first rapid animal-free bacterial endotoxin test, offers a path to reducing reliance on horseshoe crab blood.

Development 59

Development Drugs Research 59

Fierce Pharma

APRIL 1, 2024

government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. After years relying on the U.S. After years relying on the U.S.

Vaccination 79

Vaccination Vaccine Marketing 79

BioSpace

MARCH 18, 2024

To help support the launch of Lyfgenia, bluebird bio on Monday entered into a five-year term loan deal with Hercules Capital that will extend the biotech’s cash runway through the first quarter of 2026.

Gene Therapy 109

Gene Therapy Gene 109

pharmaphorum

JANUARY 10, 2024

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour subcutaneous infusion therapy for the neurodegenerative disorder.

Drugs 103

Drugs Marketing 103

pharmaphorum

APRIL 24, 2024

BeiGene has claimed a second EU approval for PD-1 inhibitor tislelizumab in non-small cell lung cancer (NSCLC), opening the door to the first launches of the drug outside China.

Drugs 73

Drugs 73

Fierce Pharma

APRIL 16, 2024

Despite a pair of clinical misfires in 2023, argenx has stuck by the thesis that its star drug Vyvgart, also known as efgartigimod, could tackle a wide array of autoimmune diseases linked to immuno | Argenx is bolstering its case for Vyvgart’s CIDP potential and preparing for a possible launch later this year—all while the company continues to prove (..)

Drugs 113

Drugs 113

Intouch Solutions

NOVEMBER 9, 2023

Meanwhile, the number of companies launching their first drug during the decade preceding 2018 more than tripled. Despite this, most of the trade chatter around launch excellence assumes the launcher is big. Yet, we know small-to-mid-sized pharma launches face a unique set of challenges. Not anymore.

Pharma Companies 105

Pharma Companies Drugs Marketing 105

BioPharma Reporter

APRIL 25, 2024

A recent Deloitte report revealed that 36% of healthcare product launches fell short of achieving 80% of their sales targets within the first two years.

Production 52

Production Sales Clinical Development Development 52

pharmaphorum

JANUARY 9, 2024

Amazon has launched an initiative with Omada Health at JPM that makes it easier for patients to discover and enrol in digital health benefit programmes

99

99

BioPharma Reporter

JANUARY 16, 2024

TrakCel, a provider of cellular orchestration systems to the cell and gene therapy (CGT) industry, has launched its own consultancy services to share its process development knowledge with the broader community of CGT developers.

Gene Therapy 97

Gene Therapy Gene Development 97